<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 03-April-2020 [02:05:44] {AM}-->
<schema targetNamespace="http://ascendispharma.com/20191231" elementFormDefault="qualified" xmlns:asnd="http://ascendispharma.com/20191231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2018-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31">
<annotation>
<appinfo>
<link:roleType roleURI="http://ascendispharma.com/role/CoverPage" id="CoverPage">
<link:definition>1001 - Document - Cover Page</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome" id="ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome">
<link:definition>1002 - Statement - Consolidated Statements of Profit or Loss and Other Comprehensive Income</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeParenthetical" id="ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeParenthetical">
<link:definition>1003 - Statement - Consolidated Statements of Profit or Loss and Other Comprehensive Income (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ConsolidatedStatementsOfFinancialPosition" id="ConsolidatedStatementsOfFinancialPosition">
<link:definition>1004 - Statement - Consolidated Statements of Financial Position</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ConsolidatedStatementsOfChangesInEquity" id="ConsolidatedStatementsOfChangesInEquity">
<link:definition>1005 - Statement - Consolidated Statements of Changes in Equity</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ConsolidatedCashFlowStatements" id="ConsolidatedCashFlowStatements">
<link:definition>1006 - Statement - Consolidated Cash Flow Statements</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/GeneralInformation" id="GeneralInformation">
<link:definition>1007 - Disclosure - General Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition>1008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CriticalAccountingJudgmentsAndKeySourcesOfEstimationUncertainty" id="CriticalAccountingJudgmentsAndKeySourcesOfEstimationUncertainty">
<link:definition>1009 - Disclosure - Critical Accounting Judgments and Key Sources of Estimation Uncertainty</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/Revenue" id="Revenue">
<link:definition>1010 - Disclosure - Revenue</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SegmentInformation" id="SegmentInformation">
<link:definition>1011 - Disclosure - Segment Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/StaffCost" id="StaffCost">
<link:definition>1012 - Disclosure - Staff Cost</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/FinanceIncomeAndFinanceExpenses" id="FinanceIncomeAndFinanceExpenses">
<link:definition>1013 - Disclosure - Finance Income and Finance Expenses</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/TaxOnProfitLossForTheYearAndDeferredTax" id="TaxOnProfitLossForTheYearAndDeferredTax">
<link:definition>1014 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/IntangibleAssets" id="IntangibleAssets">
<link:definition>1015 - Disclosure - Intangible Assets</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/PropertyPlantAndEquipment" id="PropertyPlantAndEquipment">
<link:definition>1016 - Disclosure - Property, Plant and Equipment</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/InvestmentInAssociate" id="InvestmentInAssociate">
<link:definition>1017 - Disclosure - Investment in Associate</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ShareCapital" id="ShareCapital">
<link:definition>1018 - Disclosure - Share Capital</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/DistributableEquity" id="DistributableEquity">
<link:definition>1019 - Disclosure - Distributable Equity</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/Leases" id="Leases">
<link:definition>1020 - Disclosure - Leases</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ContractLiabilities" id="ContractLiabilities">
<link:definition>1021 - Disclosure - Contract liabilities</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/OtherCommitmentsAndContingencies" id="OtherCommitmentsAndContingencies">
<link:definition>1022 - Disclosure - Other Commitments and Contingencies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/FinancialRiskManagementAndFinancialInstruments" id="FinancialRiskManagementAndFinancialInstruments">
<link:definition>1023 - Disclosure - Financial Risk Management and Financial Instruments</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
<link:definition>1024 - Disclosure - Related Party Transactions</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/InvestmentsInGroupEnterprises" id="InvestmentsInGroupEnterprises">
<link:definition>1025 - Disclosure - Investments in Group Enterprises</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/Ownership" id="Ownership">
<link:definition>1026 - Disclosure - Ownership</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition>1027 - Disclosure - Subsequent Events</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition>1028 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
<link:definition>1029 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/RevenueTables" id="RevenueTables">
<link:definition>1030 - Disclosure - Revenue (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SegmentInformationTables" id="SegmentInformationTables">
<link:definition>1031 - Disclosure - Segment Information (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/StaffCostTables" id="StaffCostTables">
<link:definition>1032 - Disclosure - Staff Cost (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/FinanceIncomeAndFinanceExpensesTables" id="FinanceIncomeAndFinanceExpensesTables">
<link:definition>1033 - Disclosure - Finance Income and Finance Expenses (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/TaxOnProfitLossForTheYearAndDeferredTaxTables" id="TaxOnProfitLossForTheYearAndDeferredTaxTables">
<link:definition>1034 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
<link:definition>1035 - Disclosure - Intangible Assets (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/PropertyPlantAndEquipmentTables" id="PropertyPlantAndEquipmentTables">
<link:definition>1036 - Disclosure - Property, Plant and Equipment (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/InvestmentInAssociateTables" id="InvestmentInAssociateTables">
<link:definition>1037 - Disclosure - Investment in Associate (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ShareCapitalTables" id="ShareCapitalTables">
<link:definition>1038 - Disclosure - Share Capital (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/LeasesTables" id="LeasesTables">
<link:definition>1039 - Disclosure - Leases (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/FinancialRiskManagementAndFinancialInstrumentsTables" id="FinancialRiskManagementAndFinancialInstrumentsTables">
<link:definition>1040 - Disclosure - Financial Risk Management and Financial Instruments (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/InvestmentsInGroupEnterprisesTables" id="InvestmentsInGroupEnterprisesTables">
<link:definition>1041 - Disclosure - Investments in Group Enterprises (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
<link:definition>1042 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAssetsExpectedUsefulLifeDetail" id="SummaryOfSignificantAccountingPoliciesScheduleOfAssetsExpectedUsefulLifeDetail">
<link:definition>1043 - Disclosure - Summary of Significant Accounting Policies - Schedule of Asset's Expected Useful Life (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfLeaseLiabilitiesRecognizedInTheConsolidatedFinancialPositionDetail" id="SummaryOfSignificantAccountingPoliciesSummaryOfLeaseLiabilitiesRecognizedInTheConsolidatedFinancialPositionDetail">
<link:definition>1044 - Disclosure - Summary of Significant Accounting Policies - Summary of Lease Liabilities Recognized in the Consolidated Financial Position (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CriticalAccountingJudgmentsAndKeySourcesOfEstimationUncertaintyAdditionalInformationDetail" id="CriticalAccountingJudgmentsAndKeySourcesOfEstimationUncertaintyAdditionalInformationDetail">
<link:definition>1045 - Disclosure - Critical Accounting Judgments and Key Sources of Estimation Uncertainty - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInConsolidatedStatementsOfProfitOrLossDetail" id="RevenueScheduleOfRevenueRecognizedInConsolidatedStatementsOfProfitOrLossDetail">
<link:definition>1046 - Disclosure - Revenue - Schedule of Revenue Recognized in Consolidated Statements of Profit or Loss (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/RevenueAdditionalInformationDetail" id="RevenueAdditionalInformationDetail">
<link:definition>1047 - Disclosure - Revenue - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SegmentInformationAdditionalInformationDetail" id="SegmentInformationAdditionalInformationDetail">
<link:definition>1048 - Disclosure - Segment Information - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SegmentInformationSummaryOfIntangibleAssetsAndPropertyPlantAndEquipmentDetail" id="SegmentInformationSummaryOfIntangibleAssetsAndPropertyPlantAndEquipmentDetail">
<link:definition>1049 - Disclosure - Segment Information - Summary of Intangible Assets, and Property, Plant and Equipment (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/StaffCostSummaryOfStaffingCostDetail" id="StaffCostSummaryOfStaffingCostDetail">
<link:definition>1050 - Disclosure - Staff Cost - Summary of Staffing Cost (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/StaffCostSummaryOfStaffCostsRecognizedInTheStatementOfProfitAndLossDetail" id="StaffCostSummaryOfStaffCostsRecognizedInTheStatementOfProfitAndLossDetail">
<link:definition>1051 - Disclosure - Staff Cost - Summary of Staff Costs Recognized in the Statement of Profit and Loss (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/StaffCostAdditionalInformationDetail" id="StaffCostAdditionalInformationDetail">
<link:definition>1052 - Disclosure - Staff Cost - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/StaffCostWarrantActivityAdditionalInformationDetail" id="StaffCostWarrantActivityAdditionalInformationDetail">
<link:definition>1053 - Disclosure - Staff Cost - Warrant Activity - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/StaffCostSummaryOfWarrantCompensationCostDetail" id="StaffCostSummaryOfWarrantCompensationCostDetail">
<link:definition>1054 - Disclosure - Staff Cost - Summary of Warrant Compensation Cost (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/StaffCostScheduleOfWarrantActivityDetail" id="StaffCostScheduleOfWarrantActivityDetail">
<link:definition>1055 - Disclosure - Staff Cost - Schedule of Warrant Activity (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/StaffCostScheduleOfWarrantActivityParentheticalDetail" id="StaffCostScheduleOfWarrantActivityParentheticalDetail">
<link:definition>1056 - Disclosure - Staff Cost - Schedule of Warrant Activity (Parenthetical) (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/StaffCostScheduleOfWeightedAverageExercisePriceAndWeightedRemainingContractualLifeForOutstandingWarrantsDetail" id="StaffCostScheduleOfWeightedAverageExercisePriceAndWeightedRemainingContractualLifeForOutstandingWarrantsDetail">
<link:definition>1057 - Disclosure - Staff Cost - Schedule of Weighted Average Exercise Price and Weighted Remaining Contractual Life for Outstanding Warrants (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/StaffCostSummaryOfFairValuesForWarrantGrantsDetail" id="StaffCostSummaryOfFairValuesForWarrantGrantsDetail">
<link:definition>1058 - Disclosure - Staff Cost - Summary of Fair Values for Warrant Grants (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/FinanceIncomeAndFinanceExpensesScheduleOfFinanceIncomeAndFinanceExpensesDetail" id="FinanceIncomeAndFinanceExpensesScheduleOfFinanceIncomeAndFinanceExpensesDetail">
<link:definition>1059 - Disclosure - Finance Income and Finance Expenses - Schedule of Finance Income and Finance Expenses (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/TaxOnProfitLossForTheYearAndDeferredTaxSummaryOfTaxOnProfitLossAndDeferredTaxDetail" id="TaxOnProfitLossForTheYearAndDeferredTaxSummaryOfTaxOnProfitLossAndDeferredTaxDetail">
<link:definition>1060 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax - Summary of Tax on Profit/Loss and Deferred Tax (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/TaxOnProfitLossForTheYearAndDeferredTaxSummaryOfTaxOnProfitLossAndDeferredTaxParentheticalDetail" id="TaxOnProfitLossForTheYearAndDeferredTaxSummaryOfTaxOnProfitLossAndDeferredTaxParentheticalDetail">
<link:definition>1061 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax - Summary of Tax on Profit/Loss and Deferred Tax (Parenthetical) (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/TaxOnProfitLossForTheYearAndDeferredTaxAdditionalInformationDetail" id="TaxOnProfitLossForTheYearAndDeferredTaxAdditionalInformationDetail">
<link:definition>1062 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/IntangibleAssetsSummaryOfGoodwillDetail" id="IntangibleAssetsSummaryOfGoodwillDetail">
<link:definition>1063 - Disclosure - Intangible Assets - Summary of Goodwill (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail" id="PropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetail">
<link:definition>1064 - Disclosure - Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/PropertyPlantAndEquipmentAdditionalInformationDetail" id="PropertyPlantAndEquipmentAdditionalInformationDetail">
<link:definition>1065 - Disclosure - Property, Plant and Equipment - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/PropertyPlantAndEquipmentSummaryOfDepreciationsChargesDetail" id="PropertyPlantAndEquipmentSummaryOfDepreciationsChargesDetail">
<link:definition>1066 - Disclosure - Property, Plant and Equipment - Summary of Depreciations Charges (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/InvestmentInAssociateAdditionalInformationDetail" id="InvestmentInAssociateAdditionalInformationDetail">
<link:definition>1067 - Disclosure - Investment in Associate - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/InvestmentInAssociateScheduleOfFinancialInformationOfInvestmentInVisenDetail" id="InvestmentInAssociateScheduleOfFinancialInformationOfInvestmentInVisenDetail">
<link:definition>1068 - Disclosure - Investment in Associate - Schedule of Financial Information of Investment in VISEN (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/InvestmentInAssociateEquityDetail" id="InvestmentInAssociateEquityDetail">
<link:definition>1069 - Disclosure - Investment in Associate - Equity (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail" id="ShareCapitalAdditionalInformationDetail">
<link:definition>1070 - Disclosure - Share Capital - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ShareCapitalSummaryOfNumberOfSharesDetail" id="ShareCapitalSummaryOfNumberOfSharesDetail">
<link:definition>1071 - Disclosure - Share Capital - Summary of Number of Shares (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/LeasesAdditionalInformationDetail" id="LeasesAdditionalInformationDetail">
<link:definition>1072 - Disclosure - Leases - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/LeasesSummaryOfDevelopmentInLeaseLiabilitiesDetail" id="LeasesSummaryOfDevelopmentInLeaseLiabilitiesDetail">
<link:definition>1073 - Disclosure - Leases - Summary of Development In Lease Liabilities (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/LeasesSummaryOfExpensesRelatingToLeaseActivitiesInTheConsolidatedStatementsDetail" id="LeasesSummaryOfExpensesRelatingToLeaseActivitiesInTheConsolidatedStatementsDetail">
<link:definition>1074 - Disclosure - Leases - Summary of Expenses, Relating To Lease Activities In The Consolidated Statements (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ContractLiabilitiesAdditionalInformationDetail" id="ContractLiabilitiesAdditionalInformationDetail">
<link:definition>1075 - Disclosure - Contract Liabilities - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/OtherCommitmentsAndContingenciesAdditionalInformationDetail" id="OtherCommitmentsAndContingenciesAdditionalInformationDetail">
<link:definition>1076 - Disclosure - Other Commitments and Contingencies - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/FinancialRiskManagementAndFinancialInstrumentsScheduleOfFinancialAssetsAndLiabilitiesDetail" id="FinancialRiskManagementAndFinancialInstrumentsScheduleOfFinancialAssetsAndLiabilitiesDetail">
<link:definition>1077 - Disclosure - Financial Risk Management and Financial Instruments - Schedule of Financial assets and Liabilities (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/FinancialRiskManagementAndFinancialInstrumentsAdditionalInformationDetail" id="FinancialRiskManagementAndFinancialInstrumentsAdditionalInformationDetail">
<link:definition>1078 - Disclosure - Financial Risk Management and Financial Instruments - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/FinancialRiskManagementAndFinancialInstrumentsScheduleOfForeignCurrencySensitivityAnalysisDetail" id="FinancialRiskManagementAndFinancialInstrumentsScheduleOfForeignCurrencySensitivityAnalysisDetail">
<link:definition>1079 - Disclosure - Financial Risk Management and Financial Instruments - Schedule of Foreign Currency Sensitivity Analysis (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/FinancialRiskManagementAndFinancialInstrumentsLiquidityRiskManagementDetail" id="FinancialRiskManagementAndFinancialInstrumentsLiquidityRiskManagementDetail">
<link:definition>1080 - Disclosure - Financial Risk Management and Financial Instruments - Liquidity Risk Management (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/InvestmentsInGroupEnterprisesSummaryOfInvestmentsInGroupEnterprisesDetail" id="InvestmentsInGroupEnterprisesSummaryOfInvestmentsInGroupEnterprisesDetail">
<link:definition>1081 - Disclosure - Investments in Group Enterprises - Summary of Investments in Group Enterprises (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/OwnershipAdditionalInformationDetail" id="OwnershipAdditionalInformationDetail">
<link:definition>1082 - Disclosure - Ownership - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="asnd-20191231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="asnd-20191231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="asnd-20191231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="asnd-20191231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/exch/2018-01-31" schemaLocation="https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
<import namespace="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd" />
<import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
<import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
<element name="AmericanDepositarySharesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_AmericanDepositarySharesMember" substitutionGroup="xbrli:item" />
<element name="StatementTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_StatementTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="Warrant1Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_Warrant1Member" substitutionGroup="xbrli:item" />
<element name="StatementLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_StatementLineItems" substitutionGroup="xbrli:item" />
<element name="NonCurrentAssetsFinanceLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_NonCurrentAssetsFinanceLiabilitiesAbstract" substitutionGroup="xbrli:item" />
<element name="ReceivableFromAssociate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_ReceivableFromAssociate" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DistributableEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_DistributableEquity" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="CostsOfCapitalIncreaseDecrease" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_CostsOfCapitalIncreaseDecrease" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="NoncashConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_NoncashConsideration" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ChangesInWorkingCapitalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_ChangesInWorkingCapitalAbstract" substitutionGroup="xbrli:item" />
<element name="AdjustmentsForIncreaseDecreaseInOperatingLeaseDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_AdjustmentsForIncreaseDecreaseInOperatingLeaseDeposits" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="AdjustmentsForIncreaseDecreaseInPrepayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_AdjustmentsForIncreaseDecreaseInPrepayments" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="AdjustmentsForDecreaseIncreaseInReceivables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_AdjustmentsForDecreaseIncreaseInReceivables" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_TextBlockAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfFinanceAndIncomeExpenseExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfFinanceAndIncomeExpenseExplanatory" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDistributableEquityExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfDistributableEquityExplanatory" substitutionGroup="xbrli:item" />
<element name="TextBlockAbstractAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_TextBlockAbstractAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfFinancialInstrumentsAndFinancialRiskManagementExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfFinancialInstrumentsAndFinancialRiskManagementExplanatory" substitutionGroup="xbrli:item" />
<element name="DisclosureOfBeneficialOwnershipExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfBeneficialOwnershipExplanatory" substitutionGroup="xbrli:item" />
<element name="DescriptionOfAccountingPolicyForAllowanceForExpectedCreditLossesOnFinancialAssetsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DescriptionOfAccountingPolicyForAllowanceForExpectedCreditLossesOnFinancialAssetsExplanatory" substitutionGroup="xbrli:item" />
<element name="DescriptionOfAccountingPolicyForChangesInAccountingPoliciesAndDisclosuresExpalanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesAndDisclosuresExpalanatory" substitutionGroup="xbrli:item" />
<element name="DescriptionOfAccountingPolicyForDeferredRevenuesAndContractLiabilitiesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DescriptionOfAccountingPolicyForDeferredRevenuesAndContractLiabilitiesExplanatory" substitutionGroup="xbrli:item" />
<element name="DescriptionOfAccountingPolicyForDilutedEarningsPerShareExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DescriptionOfAccountingPolicyForDilutedEarningsPerShareExplanatory" substitutionGroup="xbrli:item" />
<element name="DescriptionOfAccountingPolicyForOtherPayablesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DescriptionOfAccountingPolicyForOtherPayablesExplanatory" substitutionGroup="xbrli:item" />
<element name="DescriptionOfAccountingPolicyForPrepaymentsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DescriptionOfAccountingPolicyForPrepaymentsExplanatory" substitutionGroup="xbrli:item" />
<element name="DescriptionOfAccountingPolicyForStockholdersEquityExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DescriptionOfAccountingPolicyForStockholdersEquityExplanatory" substitutionGroup="xbrli:item" />
<element name="DescriptionOfAccountingPolicyForTradePayablesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DescriptionOfAccountingPolicyForTradePayablesExplanatory" substitutionGroup="xbrli:item" />
<element name="DescriptionOfBasisOfConsolidationExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DescriptionOfBasisOfConsolidationExplanatory" substitutionGroup="xbrli:item" />
<element name="DescriptionOfConsolidationPrinciplesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DescriptionOfConsolidationPrinciplesExplanatory" substitutionGroup="xbrli:item" />
<element name="DescriptionOfAccountingPolicyForDepreciationUnderPropertyPlantAndEquipmentExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DescriptionOfAccountingPolicyForDepreciationUnderPropertyPlantAndEquipmentExplanatory" substitutionGroup="xbrli:item" />
<element name="DisclosureOfImpactOfIfrs16ApplicationOnConsolidatedStatementsOfFinancialPositionExplanatoryTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfImpactOfIfrs16ApplicationOnConsolidatedStatementsOfFinancialPositionExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfSegmentRevenuesByDestinationOfMajorCustomersExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfSegmentRevenuesByDestinationOfMajorCustomersExplanatory" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutStaffingCostExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfDetailedInformationAboutStaffingCostExplanatory" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutStaffingCostRecognisedInProfitAndLossExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfDetailedInformationAboutStaffingCostRecognisedInProfitAndLossExplanatory" substitutionGroup="xbrli:item" />
<element name="DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingOtherEquityInstrumentsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingOtherEquityInstrumentsExplanatory" substitutionGroup="xbrli:item" />
<element name="DisclosureOfWarrantCompensationsCostExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfWarrantCompensationsCostExplanatory" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutDepreciationsCharges" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfDetailedInformationAboutDepreciationsCharges" substitutionGroup="xbrli:item" />
<element name="VisenPharmaceuticalMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_VisenPharmaceuticalMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfExpensesRelatingToLeaseActivitiesInTheConsolidatedStatements" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfExpensesRelatingToLeaseActivitiesInTheConsolidatedStatements" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDevelopmentInLeaseLiabilitiesTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfDevelopmentInLeaseLiabilitiesTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfFinancialAssetsAndLiabilitiesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory" substitutionGroup="xbrli:item" />
<element name="DisclosureOfForeignCurrencySensitivityAnalysisExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfForeignCurrencySensitivityAnalysisExplanatory" substitutionGroup="xbrli:item" />
<element name="DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfSummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems" substitutionGroup="xbrli:item" />
<element name="NumberOfFinaceLeases" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_NumberOfFinaceLeases" substitutionGroup="xbrli:item" />
<element name="NumberOfReportableOperatingSegments" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_NumberOfReportableOperatingSegments" substitutionGroup="xbrli:item" />
<element name="OperatingLeaseCommitments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_OperatingLeaseCommitments" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="Ifrs16Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_Ifrs16Member" substitutionGroup="xbrli:item" />
<element name="OtherFixturesAndFittingsToolsAndEquipmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_OtherFixturesAndFittingsToolsAndEquipmentMember" substitutionGroup="xbrli:item" />
<element name="ProcessPlantAndMachineryMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_ProcessPlantAndMachineryMember" substitutionGroup="xbrli:item" />
<element name="ExpenseRelatingToLeasesOfShorttermContractsAndLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_ExpenseRelatingToLeasesOfShorttermContractsAndLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="UndiscountedOperatingLeaseCommitments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_UndiscountedOperatingLeaseCommitments" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="NumberOfCollaborationAgreements" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_NumberOfCollaborationAgreements" substitutionGroup="xbrli:item" />
<element name="NumberOfLicenses" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_NumberOfLicenses" substitutionGroup="xbrli:item" />
<element name="NumberOfTranches" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_NumberOfTranches" substitutionGroup="xbrli:item" />
<element name="AdditionalLeasePeriodInAdditonToNonCancellablePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_AdditionalLeasePeriodInAdditonToNonCancellablePeriod" substitutionGroup="xbrli:item" />
<element name="ProjectCostPrepaymentsCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_ProjectCostPrepaymentsCurrent" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ProjectCostAccrualsCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_ProjectCostAccrualsCurrent" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="EurOrDkkMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_EurOrDkkMember" substitutionGroup="xbrli:item" />
<element name="RevenueFromSaleOfClinicalSupply" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_RevenueFromSaleOfClinicalSupply" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="CustomerOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_CustomerOneMember" substitutionGroup="xbrli:item" />
<element name="NorthAmerica1Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_NorthAmerica1Member" substitutionGroup="xbrli:item" />
<element name="Germany1Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_Germany1Member" substitutionGroup="xbrli:item" />
<element name="DisclosureOfEmployeeCompensationCostsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfEmployeeCompensationCostsAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfEmployeeCompensationCostsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfEmployeeCompensationCostsTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfEmployeeCompensationCostsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfEmployeeCompensationCostsLineItems" substitutionGroup="xbrli:item" />
<element name="IncomeStatementLocationAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_IncomeStatementLocationAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="IncomeStatementLocation1Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_IncomeStatementLocation1Member" substitutionGroup="xbrli:item" />
<element name="GeneralAndAdministrativeExpenseMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_GeneralAndAdministrativeExpenseMember" substitutionGroup="xbrli:item" />
<element name="ResearchAndDevelopmentCostsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_ResearchAndDevelopmentCostsMember" substitutionGroup="xbrli:item" />
<element name="BoardOfDirectorsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_BoardOfDirectorsMember" substitutionGroup="xbrli:item" />
<element name="ExecutiveBoardMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_ExecutiveBoardMember" substitutionGroup="xbrli:item" />
<element name="NumberOfEmployees1" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_NumberOfEmployees1" substitutionGroup="xbrli:item" />
<element name="AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" substitutionGroup="xbrli:item" />
<element name="BonusIssuanceOfSharesRatio" type="xbrli:pureItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_BonusIssuanceOfSharesRatio" substitutionGroup="xbrli:item" />
<element name="BonusSharesIssuanceWarrantsAdjustmentRatio" type="xbrli:pureItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_BonusSharesIssuanceWarrantsAdjustmentRatio" substitutionGroup="xbrli:item" />
<element name="BonusSharesIssuanceWarrantsExercisePriceAdjustmentRatio" type="xbrli:pureItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_BonusSharesIssuanceWarrantsExercisePriceAdjustmentRatio" substitutionGroup="xbrli:item" />
<element name="MinimumPercentageOfShareCapitalForEquityTransctions" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_MinimumPercentageOfShareCapitalForEquityTransctions" substitutionGroup="xbrli:item" />
<element name="NumberOfAnnualExcercisedPeriod" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_NumberOfAnnualExcercisedPeriod" substitutionGroup="xbrli:item" />
<element name="NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" substitutionGroup="xbrli:item" />
<element name="PaymentOfDividendFromEquityMaximumPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_PaymentOfDividendFromEquityMaximumPercentage" substitutionGroup="xbrli:item" />
<element name="ShareBasedPaymentArrangementVestingPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_ShareBasedPaymentArrangementVestingPeriod" substitutionGroup="xbrli:item" />
<element name="WarrantExcercisedPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_WarrantExcercisedPeriod" substitutionGroup="xbrli:item" />
<element name="WeightedAverageRemainingContractualLifeOfOutstandingOtherEquityInstruments" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_WeightedAverageRemainingContractualLifeOfOutstandingOtherEquityInstruments" substitutionGroup="xbrli:item" />
<element name="OutstandingWarrantsGrantedInConnectionWithPreferenceFinancingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_OutstandingWarrantsGrantedInConnectionWithPreferenceFinancingMember" substitutionGroup="xbrli:item" />
<element name="OutstandingWarrantsGrantedInConnectionWithPublishingAnnualOrInterimReportMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_OutstandingWarrantsGrantedInConnectionWithPublishingAnnualOrInterimReportMember" substitutionGroup="xbrli:item" />
<element name="WarrantsGrantedAfterDecemberEighteenTwoThousandEighteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_WarrantsGrantedAfterDecemberEighteenTwoThousandEighteenMember" substitutionGroup="xbrli:item" />
<element name="WarrantsIssuedDecemberTwoThousandTwelveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_WarrantsIssuedDecemberTwoThousandTwelveMember" substitutionGroup="xbrli:item" />
<element name="WarrantsIssuedFromTwoThousandEightToTwoThousandTwelveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_WarrantsIssuedFromTwoThousandEightToTwoThousandTwelveMember" substitutionGroup="xbrli:item" />
<element name="WarrantsIssuedJanuaryTwoThousandFifteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_WarrantsIssuedJanuaryTwoThousandFifteenMember" substitutionGroup="xbrli:item" />
<element name="StatementOfComprehensiveIncomeProfitOrLossLocationAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="StatementOfComprehensiveIncomeProfitOrLossLocationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" substitutionGroup="xbrli:item" />
<element name="ResearchAndDevelopmentCostMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_ResearchAndDevelopmentCostMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfWarrantActivityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfWarrantActivityLineItems" substitutionGroup="xbrli:item" />
<element name="NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" substitutionGroup="xbrli:item" />
<element name="WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" substitutionGroup="xbrli:item" />
<element name="FunctionalCurrencyAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_FunctionalCurrencyAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="FunctionalCurrencyDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_FunctionalCurrencyDomain" substitutionGroup="xbrli:item" />
<element name="USDollarsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_USDollarsMember" substitutionGroup="xbrli:item" />
<element name="YearOfGrantOfWarrants" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_YearOfGrantOfWarrants" substitutionGroup="xbrli:item" />
<element name="GrantedIn2017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_GrantedIn2017Member" substitutionGroup="xbrli:item" />
<element name="GrantedIn2018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_GrantedIn2018Member" substitutionGroup="xbrli:item" />
<element name="GrantedIn2019Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_GrantedIn2019Member" substitutionGroup="xbrli:item" />
<element name="GrantedIn2012To2016Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_GrantedIn2012To2016Member" substitutionGroup="xbrli:item" />
<element name="DescriptionsOfRiskFreeInterestRateShareOptionsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DescriptionsOfRiskFreeInterestRateShareOptionsGranted" substitutionGroup="xbrli:item" />
<element name="FairValueOfWarrantsGranted" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_FairValueOfWarrantsGranted" substitutionGroup="xbrli:item" />
<element name="FinanceIncomeExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_FinanceIncomeExpenseAbstract" substitutionGroup="xbrli:item" />
<element name="OtherTemporaryDifferencesBeforeValuationAllowances" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_OtherTemporaryDifferencesBeforeValuationAllowances" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ProfitLossBeforeIncomeTaxAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_ProfitLossBeforeIncomeTaxAbstract" substitutionGroup="xbrli:item" />
<element name="TaxEffectOfDeductibleItemsNotExpensed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_TaxEffectOfDeductibleItemsNotExpensed" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TaxEffectOfTaxCreditsNotRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_TaxEffectOfTaxCreditsNotRecognised" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TaxEffectsFromImpactsFromAssociates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_TaxEffectsFromImpactsFromAssociates" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TaxEffectFromDeferredTaxAssetNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_TaxEffectFromDeferredTaxAssetNotRecognized" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DeferredTaxAssetNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_DeferredTaxAssetNotRecognized" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TaxLossesCarryforwards" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_TaxLossesCarryforwards" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="PlantAndMachineryMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_PlantAndMachineryMember" substitutionGroup="xbrli:item" />
<element name="IncreaseDecreaseInPropertyPlantAndEquipmentDueToAdoptionOfNewLeasePolicy" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_IncreaseDecreaseInPropertyPlantAndEquipmentDueToAdoptionOfNewLeasePolicy" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="LeaseholdsImprovementsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_LeaseholdsImprovementsPayable" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DisclosureOfDetailedInformationAboutDepreciationsChargesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfDetailedInformationAboutDepreciationsChargesTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfDetailedInformationAboutDepreciationsChargesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfDetailedInformationAboutDepreciationsChargesLineItems" substitutionGroup="xbrli:item" />
<element name="DisclosureOfAssociatesAndJointVenturesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfAssociatesAndJointVenturesLineItems" substitutionGroup="xbrli:item" />
<element name="ContingentLiabilitiesOrCapitalCommitments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_ContingentLiabilitiesOrCapitalCommitments" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="RevenueFromAssociate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_RevenueFromAssociate" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AssociateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_AssociateAbstract" substitutionGroup="xbrli:item" />
<element name="ProfitLossForTheYear" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_ProfitLossForTheYear" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ShareOfEquityAfterEliminations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_ShareOfEquityAfterEliminations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ShareOfEquityBeforeEliminations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_ShareOfEquityBeforeEliminations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="IncreaseDecreaseThroughCashContribution" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_IncreaseDecreaseThroughCashContribution" substitutionGroup="xbrli:item" />
<element name="LeaseExtensionPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_LeaseExtensionPeriod" substitutionGroup="xbrli:item" />
<element name="LeaseTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_LeaseTerm" substitutionGroup="xbrli:item" />
<element name="CashOutFlowForLeasesIncludePrepaidLeases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_CashOutFlowForLeasesIncludePrepaidLeases" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AdditionsToLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_AdditionsToLeaseLiabilities" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ResearchAndDevelopmentMemberMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_ResearchAndDevelopmentMemberMember" substitutionGroup="xbrli:item" />
<element name="GeneralAndAdministrationMemberMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_GeneralAndAdministrationMemberMember" substitutionGroup="xbrli:item" />
<element name="LeaseExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_LeaseExpenses" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="RevenueRecognizedFromDeferredIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_RevenueRecognizedFromDeferredIncome" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="DisclosureOfCommitmentsAndContingenciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfCommitmentsAndContingenciesTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfCommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfCommitmentsAndContingenciesLineItems" substitutionGroup="xbrli:item" />
<element name="ForeignCurrencyTargetPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_ForeignCurrencyTargetPercentage" substitutionGroup="xbrli:item" />
<element name="IncreaseDecreaseInForeignCurrencyExchangeRate" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_IncreaseDecreaseInForeignCurrencyExchangeRate" substitutionGroup="xbrli:item" />
<element name="PercentageOfIncreaseDecreaseInSensitivityAnalysis" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_PercentageOfIncreaseDecreaseInSensitivityAnalysis" substitutionGroup="xbrli:item" />
<element name="ForeignCurrencyRiskAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_ForeignCurrencyRiskAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="ForeignCurrencyRiskDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_ForeignCurrencyRiskDomain" substitutionGroup="xbrli:item" />
<element name="NominalValueAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_NominalValueAmount" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="BritishPoundsToEuroMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_BritishPoundsToEuroMember" substitutionGroup="xbrli:item" />
<element name="UsDollarsToEuroMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_UsDollarsToEuroMember" substitutionGroup="xbrli:item" />
<element name="ContractualUndiscountedCashflowOfFinancialLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_ContractualUndiscountedCashflowOfFinancialLeaseLiabilities" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ContractualUndiscountedCashflowOfTradePayablesAndOtherPayables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_ContractualUndiscountedCashflowOfTradePayablesAndOtherPayables" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ContractualUndiscountedCashflowOfFinancialLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_ContractualUndiscountedCashflowOfFinancialLiabilities" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AscendisPharmaBoneDiseaseASMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_AscendisPharmaBoneDiseaseASMember" substitutionGroup="xbrli:item" />
<element name="AscendisPharmaEndocrinologyDivisionASMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_AscendisPharmaEndocrinologyDivisionASMember" substitutionGroup="xbrli:item" />
<element name="AscendisPharmaGmbHMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_AscendisPharmaGmbHMember" substitutionGroup="xbrli:item" />
<element name="AscendisPharmaGrowthDisordersASMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_AscendisPharmaGrowthDisordersASMember" substitutionGroup="xbrli:item" />
<element name="AscendisPharmaIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_AscendisPharmaIncMember" substitutionGroup="xbrli:item" />
<element name="AscendisPharmaOphthalmologyDivisionASMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_AscendisPharmaOphthalmologyDivisionASMember" substitutionGroup="xbrli:item" />
<element name="AscendisPharmaOncologyDivisionAsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_AscendisPharmaOncologyDivisionAsMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfBeneficialOwnershipAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfBeneficialOwnershipAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfBeneficialOwnershipTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfBeneficialOwnershipTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="BakerBrosAdvisorsLPMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_BakerBrosAdvisorsLPMember" substitutionGroup="xbrli:item" />
<element name="EntitiesAffiliatedWithFmrLlcMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_EntitiesAffiliatedWithFmrLlcMember" substitutionGroup="xbrli:item" />
<element name="EntitiesAffiliatedWithRaCapitalManagementLlcMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_EntitiesAffiliatedWithRaCapitalManagementLlcMember" substitutionGroup="xbrli:item" />
<element name="EntitiesAffiliatedWithOrbiMedPrivateInvestmentsVLPMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_EntitiesAffiliatedWithOrbiMedPrivateInvestmentsVLPMember" substitutionGroup="xbrli:item" />
<element name="TRowePriceAssociatesincMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_TRowePriceAssociatesincMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfBeneficialOwnershipLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfBeneficialOwnershipLineItems" substitutionGroup="xbrli:item" />
<element name="DescriptionOfAmericanDepositoryShares" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DescriptionOfAmericanDepositoryShares" substitutionGroup="xbrli:item" />
<element name="MajorPersonsOrGroupsOfAffiliatedPersonsHoldingMinimumBeneficialOwnership" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_MajorPersonsOrGroupsOfAffiliatedPersonsHoldingMinimumBeneficialOwnership" substitutionGroup="xbrli:item" />
<element name="MinimumBeneficialOwnershipPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_MinimumBeneficialOwnershipPercentage" substitutionGroup="xbrli:item" />
</schema>
